Boston Scientific (BSX) Acquisitions (2009 - 2026)

Boston Scientific has disclosed Acquisitions across 17 years of filings, most recently posting $195.0 million for Q2 2026.

• In Q2 2026, Acquisitions fell 80.67% year-over-year to $195.0 million; the TTM figure through Jun 2026 stood at $880.0 million (down 84.81% YoY), while the FY2025 annual figure was $1.6 billion, down 65.67% from the prior year.
• Acquisitions came in at $195.0 million for Q2 2026 at Boston Scientific, down from $523.0 million in the prior quarter.
• In the past five years, Acquisitions ranged from a high of $3.4 billion in Q4 2024 to a low of $47.0 million in Q1 2024.
• Average Acquisitions over 5 years is $674.7 million, with a median of $375.0 million recorded in 2023.
• The largest YoY upside for Acquisitions was 2002.08% in 2025 against a maximum downside of 97.4% in 2025.
• Over 5 years, Acquisitions stood at $71.0 million in 2022, then surged by 1016.9% to $793.0 million in 2023, then soared by 331.02% to $3.4 billion in 2024, then plunged by 97.4% to $89.0 million in 2025, then soared by 119.1% to $195.0 million in 2026.
• Per Business Quant data, the three most recent Acquisitions figures were $195.0 million in Q2 2026, $523.0 million in Q1 2026, and $89.0 million in Q4 2025.